Search - tctmd.com

Displaying 161 - 180 of 403

Sort: Relevancy | Date

Presentation THT 2023

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

Presenter: Gregg Stone

March 21, 2023

Presentation THT 2023

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Presenter: Scott Lim

March 21, 2023

Presentation THT 2023

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Presenter: Boaz Manash

March 21, 2023

Presentation THT 2023

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Presenter: Oleg Polonetsky

March 21, 2023

Presentation THT 2023

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

Presenter: Tyler Bonkowski

March 21, 2023

Presentation THT 2023

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

Presenter: Romy Hegeman

March 21, 2023

Presentation THT 2023

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

Presenter: Liviu Klein

March 21, 2023

News Conference News THT 2023

TEER or VAD/Transplant in the Advanced HF Patient With MR?

Shelley Wood

March 20, 2023

Presentation THT 2023

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

Presenter: Mandeep Mehra

March 20, 2023

Presentation THT 2023

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

Presenter: William Abraham

March 20, 2023

Presentation THT 2023

FDA Introduction

Presenter: Changfu Wu

March 20, 2023

News Daily News

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Michael O'Riordan

January 30, 2023

News Daily News

Top Heart Failure News of 2022

Shelley Wood

January 04, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Conference News PCR London Valves 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Impella RP Mortality Rate No Longer a Concern, FDA Says

Caitlin E. Cox

December 05, 2022

News Daily News

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Todd Neale

November 17, 2022

Advertisement

A Left Ventricular Transcatheter Repair Device for HFrEF Patients: FIH Experience With the Vsling Device

First-in-Human and Early Feasibility Study of Transcatheter Left Ventricular Myocardial Injection of Alginate Hydrogel in Heart Failure Patients – the Deke XDROP System

Vsling, A Left Ventricular Transcatheter Repair Device for HFrEF Patients

Left ventricular reconstruction compared to optimal medical therapy in patients with ischemic cardiomyopathy

Effect of Supersaturated Oxygen (SSO2) on Left Ventricular Ejection Fraction (LVEF) in LAD STEMI Patients Post PCI in the Real World: Retrospective Comparison to Control Patients

The Role of Guideline Directed Medical Therapy in Functional Improvement after Hybrid Left Ventricular Reconstruction for the Treatment of Ischemic Heart Failure

What Is the Potential Role of Shunts Across the Spectrum of LV EFs?

TEER or VAD/Transplant in the Advanced HF Patient With MR?

What Are the Pros and Cons of the Win Ratio as the Primary Endpoint for Pivotal Heart Failure Trial

What are the Strengths and Limitations of a Two-Phase (6-Month Intermediate Endpoints & 12-18 Month Mortality and Heart Failure Hospitalization) Trial Design

FDA Introduction

For Some, Hopes for a Heart Grow Dim as LVAD-Only Centers Spread

Top Heart Failure News of 2022

The Biggest News of 2022: TCTMD’s Top 10

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Impella RP Mortality Rate No Longer a Concern, FDA Says

AI Accurately Detects LV Dysfunction Using Single-Lead Apple Watch ECG

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content